FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988407645> ?p ?o ?g. }

• W1988407645 endingPage "184" @default.
• W1988407645 startingPage "178" @default.
• W1988407645 abstract "From 1986 to 1991, 13 patients at Northwestern Memorial Hospital were entered onto a pilot study designed to test the feasibility of treating children with meduUoblastoma (11 patients) or primitive neuroectodermal tumors of the cerebral hemispheres (2 patients) with hyperfractionated craniospinal radiotherapy (HFxRT). Follow-up times ranged from 10 to 96 months with a median of 53 months. The patients were prospectively divided among three treatment arms depending on prior treatment history, if any, and degree of surgical resection. The 3 patients in group I had undergone gross total resection of the primary site, receiving 64.8 Gy to the primary site and 31.2 Gy directed to the craniospinal axis (CSA). Of these 3 patients, patient 1 had residual disease in the thoracic spine at T-10. The 8 patients in group II, who had gross residual disease remaining at the primary site, received 72 Gy to the primary site and 34 Gy to the CSA. Five of these eight patients in group II also received 8-in-1 chemotherapy. The 2 patients in group III had already failed chemotherapy and were then treated with 60 Gy to the primary site and 26 Gy to the CSA. Of the 11 patients in groups I and II, 7 of the 11 (64%) have never recurred. Two of the three group-I patients have not recurred, and 5 of the 7 group-II patients have not recurred. In addition, patient 7 (group II) remains alive after salvage with bone marrow transplant, following a local failure bordering the tentorium. Unfortunately, neither of the group-III patients could be salvaged with HFxRT. Acute/subacute toxicities included 7 cases of external auditory canal or skin desquamation, 2 cases of postradiation somnolence, and 1 case each of poor wound healing and neutropenia. Chronic toxicities included hypothyroidism in 2 patients and growth problems in 2 patients. Neuropsychologic complications affected only the 3 youngest patients in the study. Three patients developed neurologic sequelae attributed to radiation, including 1 with progressive urinary incontinence, 1 who developed a transient ischemic attack, and 1 who became progressively ataxic. Our research, although based on a small number of patients, suggests that hyperfractionated radiation therapy to craniospinal access is feasible and that the survival results are favorable. This treatment strategy should be further explored in a phase-III randomized trial." @default.
• W1988407645 created "2016-06-24" @default.
• W1988407645 creator A5000384489 @default.
• W1988407645 creator A5020621550 @default.
• W1988407645 creator A5039680305 @default.
• W1988407645 creator A5046770754 @default.
• W1988407645 creator A5080547802 @default.
• W1988407645 creator A5087119700 @default.
• W1988407645 date "1996-01-01" @default.
• W1988407645 modified "2023-10-16" @default.
• W1988407645 title "Hyperf ractionated Craniospinal Radiation in Medulloblastoma" @default.
• W1988407645 doi "https://doi.org/10.1159/000121035" @default.
• W1988407645 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8873159" @default.
• W1988407645 hasPublicationYear "1996" @default.
• W1988407645 type Work @default.
• W1988407645 sameAs 1988407645 @default.
• W1988407645 citedByCount "19" @default.
• W1988407645 countsByYear W19884076452012 @default.
• W1988407645 countsByYear W19884076452013 @default.
• W1988407645 countsByYear W19884076452014 @default.
• W1988407645 crossrefType "journal-article" @default.
• W1988407645 hasAuthorship W1988407645A5000384489 @default.
• W1988407645 hasAuthorship W1988407645A5020621550 @default.
• W1988407645 hasAuthorship W1988407645A5039680305 @default.
• W1988407645 hasAuthorship W1988407645A5046770754 @default.
• W1988407645 hasAuthorship W1988407645A5080547802 @default.
• W1988407645 hasAuthorship W1988407645A5087119700 @default.
• W1988407645 hasConcept C141071460 @default.
• W1988407645 hasConcept C2776694085 @default.
• W1988407645 hasConcept C2779281540 @default.
• W1988407645 hasConcept C2780789225 @default.
• W1988407645 hasConcept C502942594 @default.
• W1988407645 hasConcept C509974204 @default.
• W1988407645 hasConcept C71924100 @default.
• W1988407645 hasConceptScore W1988407645C141071460 @default.
• W1988407645 hasConceptScore W1988407645C2776694085 @default.
• W1988407645 hasConceptScore W1988407645C2779281540 @default.
• W1988407645 hasConceptScore W1988407645C2780789225 @default.
• W1988407645 hasConceptScore W1988407645C502942594 @default.
• W1988407645 hasConceptScore W1988407645C509974204 @default.
• W1988407645 hasConceptScore W1988407645C71924100 @default.
• W1988407645 hasIssue "4" @default.
• W1988407645 hasLocation W19884076451 @default.
• W1988407645 hasLocation W19884076452 @default.
• W1988407645 hasOpenAccess W1988407645 @default.
• W1988407645 hasPrimaryLocation W19884076451 @default.
• W1988407645 hasRelatedWork W1946468667 @default.
• W1988407645 hasRelatedWork W1984648251 @default.
• W1988407645 hasRelatedWork W2029871845 @default.
• W1988407645 hasRelatedWork W2064166706 @default.
• W1988407645 hasRelatedWork W2087140558 @default.
• W1988407645 hasRelatedWork W2105192854 @default.
• W1988407645 hasRelatedWork W2109552359 @default.
• W1988407645 hasRelatedWork W2135275068 @default.
• W1988407645 hasRelatedWork W2382209557 @default.
• W1988407645 hasRelatedWork W2416576497 @default.
• W1988407645 hasVolume "24" @default.
• W1988407645 isParatext "false" @default.
• W1988407645 isRetracted "false" @default.
• W1988407645 magId "1988407645" @default.
• W1988407645 workType "article" @default.